Fredrik Piehl Selected Research

Wounds and Injuries (Trauma)

12/2021	Fluid proteomics of CSF and serum reveal important neuroinflammatory proteins in blood-brain barrier disruption and outcome prediction following severe traumatic brain injury: a prospective, observational study.
5/2013	Genetic variability in the rat Aplec C-type lectin gene cluster regulates lymphocyte trafficking and motor neuron survival after traumatic nerve root injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fredrik Piehl Research Topics

Disease

77	Multiple Sclerosis 05/2024 - 06/2004
27	Relapsing-Remitting Multiple Sclerosis 05/2024 - 01/2015
16	Inflammation (Inflammations) 03/2024 - 10/2003
12	Psychotic Disorders (Schizoaffective Disorder) 01/2024 - 01/2018
11	Infections 05/2024 - 01/2012
10	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2024 - 01/2013
10	Schizophrenia (Dementia Praecox) 01/2024 - 01/2019
10	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 07/2009
9	Myasthenia Gravis 02/2024 - 03/2016
8	Disease Progression 12/2023 - 01/2013
7	Neuroinflammatory Diseases 03/2024 - 04/2013
5	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2020 - 10/2003
4	Fatigue 05/2024 - 03/2016
4	Neoplasms (Cancer) 03/2024 - 01/2015
4	COVID-19 12/2023 - 12/2021
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 05/2011
3	Thymoma (Thymic Carcinoma) 02/2024 - 11/2019
3	Nervous System Diseases (Neurological Disorders) 01/2024 - 01/2016
3	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 01/2013
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 10/2023 - 01/2018
3	Cognitive Dysfunction 08/2023 - 11/2019
3	Normal Pressure Hydrocephalus 01/2021 - 09/2019
3	Encephalitis (Encephalitis, Rasmussen) 11/2017 - 08/2010
3	Rheumatoid Arthritis 01/2017 - 05/2005
2	Parkinson Disease (Parkinson's Disease) 01/2024 - 01/2020
2	Pain (Aches) 08/2023 - 03/2013
2	Wounds and Injuries (Trauma) 12/2021 - 05/2013
2	Autoimmune Diseases of the Nervous System 11/2021 - 03/2015
2	Progressive Multifocal Leukoencephalopathy 05/2021 - 06/2016
2	Brain Injuries (Brain Injury) 01/2021 - 09/2019
2	Atrophy 01/2021 - 01/2020
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2020 - 02/2019
2	Demyelinating Diseases (Demyelinating Disease) 01/2020 - 01/2020
2	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 02/2019 - 03/2015
2	Hypoxia (Hypoxemia) 01/2017 - 07/2002
2	Central Nervous System Diseases (CNS Diseases) 01/2015 - 02/2014
2	Herpes Simplex 01/2012 - 08/2010
1	Muscle Weakness 02/2024

Drug/Important Bio-Agent (IBA)

32	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2013
27	Rituximab (Mabthera)FDA Link 05/2024 - 02/2016
13	Proteins (Proteins, Gene)FDA Link 01/2024 - 04/2013
13	Natalizumab (Tysabri)FDA Link 11/2023 - 01/2011
10	Polytetrafluoroethylene (Teflon)FDA Link 01/2024 - 01/2019
8	Fingolimod Hydrochloride (FTY720)FDA Link 12/2023 - 06/2016
7	AutoantibodiesIBA 03/2024 - 06/2017
7	AntibodiesIBA 02/2024 - 02/2015
7	Dimethyl FumarateIBA 01/2022 - 02/2018
4	Complement System Proteins (Complement)IBA 01/2024 - 01/2013
4	Alemtuzumab (Campath)FDA Link 01/2022 - 01/2020
4	ocrelizumabIBA 01/2022 - 01/2018
4	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2021 - 03/2015
4	CytokinesIBA 01/2019 - 05/2004
3	Glial Fibrillary Acidic ProteinIBA 03/2024 - 01/2023
3	Cholinergic ReceptorsIBA 02/2024 - 03/2016
3	Messenger RNA (mRNA)IBA 01/2024 - 06/2004
3	Blood Proteins (Serum Proteins)IBA 01/2023 - 10/2019
3	Glatiramer Acetate (Copaxone)FDA Link 01/2022 - 01/2018
3	insulin receptor-related receptor (IRR)IBA 10/2020 - 01/2015
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 07/2002
3	MHC class II transactivator proteinIBA 07/2009 - 05/2005
2	Anti-Bacterial Agents (Antibiotics)IBA 05/2024 - 01/2016
2	TabletsIBA 12/2023 - 01/2022
2	Cladribine FDA LinkGeneric 12/2023 - 01/2022
2	teriflunomideIBA 08/2023 - 01/2022
2	Tumor Necrosis Factor Ligand Superfamily Member 14IBA 08/2023 - 11/2017
2	Lipocalin-2IBA 01/2023 - 02/2016
2	Dopamine (Intropin)FDA LinkGeneric 01/2023 - 01/2022
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2023 - 01/2013
2	Immunosuppressive Agents (Immunosuppressants)IBA 11/2022 - 01/2020
2	InterferonsIBA 01/2022 - 12/2020
2	Peptides (Polypeptides)IBA 01/2021 - 01/2017
2	AntioxidantsIBA 01/2021 - 01/2015
2	KynurenineIBA 01/2021 - 03/2020
2	NeurocanIBA 01/2021 - 09/2019
2	BrevicanIBA 01/2021 - 09/2019
2	Immunoglobulins (Immunoglobulin)IBA 10/2020 - 01/2019
2	Interferon-betaIBA 01/2020 - 01/2018
2	tocilizumab (atlizumab)FDA Link 11/2019 - 06/2017
2	Retinaldehyde (Retinal)IBA 11/2019 - 01/2017
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2019 - 10/2014
2	MicroRNAs (MicroRNA)IBA 01/2019 - 06/2016
2	ChemokinesIBA 01/2019 - 10/2003
2	CXC ChemokinesIBA 01/2019 - 01/2013
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2018 - 03/2013
2	HLA-DRB1 Chains (HLA DRB1)IBA 01/2018 - 01/2016
2	SphingolipidsIBA 01/2018 - 09/2015
2	ButyrylcholinesteraseIBA 01/2015 - 11/2013
2	C-Type Lectins (C-Type Lectin)IBA 12/2014 - 05/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2011 - 07/2002
2	Myelin-Oligodendrocyte GlycoproteinIBA 03/2008 - 10/2003

Therapy/Procedure

30	Therapeutics 05/2024 - 06/2016
4	Immunotherapy 05/2024 - 01/2020
4	Stem Cell Transplantation 09/2023 - 02/2015
3	Thymectomy 02/2024 - 11/2019
3	Activities of Daily Living (ADL) 11/2022 - 01/2019
2	Duration of Therapy 05/2024 - 11/2022
2	Off-Label Use 03/2024 - 01/2020
2	Critical Care (Surgical Intensive Care) 01/2022 - 02/2019
2	Hematopoietic Stem Cell Transplantation 01/2021 - 02/2015
2	Transplantation 01/2016 - 02/2015